Filing Details

Accession Number:
0001735276-25-000009
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-02-18 16:47:04
Reporting Period:
2025-02-13
Filing Date:
2025-02-18
Accepted Time:
2025-02-18 16:47:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1178670 Alnylam Pharmaceuticals Inc. ALNY ()
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1829252 Pushkal Garg 675 West Kendall Street
Henri A. Termeer Square
Cambridge MA 02142
Cmo & Evp Dev & Med Affairs No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2025-02-13 3,109 $0.00 15,098 No 4 A Direct
Common Stock Disposition 2025-02-14 349 $252.50 14,749 No 4 S Direct
Common Stock Disposition 2025-02-14 386 $253.37 14,363 No 4 S Direct
Common Stock Disposition 2025-02-14 258 $254.35 14,105 No 4 S Direct
Common Stock Disposition 2025-02-14 110 $255.56 13,995 No 4 S Direct
Common Stock Disposition 2025-02-14 126 $256.29 13,869 No 4 S Direct
Common Stock Disposition 2025-02-14 60 $257.51 13,809 No 4 S Direct
Common Stock Disposition 2025-02-14 77 $258.07 13,732 No 4 S Direct
Common Stock Disposition 2025-02-14 27 $259.72 13,705 No 4 S Direct
Common Stock Disposition 2025-02-14 49 $260.57 13,656 No 4 S Direct
Common Stock Disposition 2025-02-14 60 $261.45 13,596 No 4 S Direct
Common Stock Disposition 2025-02-14 27 $263.33 13,569 No 4 S Direct
Common Stock Disposition 2025-02-14 32 $264.87 13,537 No 4 S Direct
Common Stock Disposition 2025-02-18 862 $250.11 12,675 No 4 S Direct
Common Stock Disposition 2025-02-18 306 $250.73 12,369 No 4 S Direct
Common Stock Disposition 2025-02-18 110 $251.60 12,259 No 4 S Direct
Common Stock Disposition 2025-02-18 83 $256.05 12,176 No 4 S Direct
Common Stock Disposition 2025-02-18 107 $257.99 12,069 No 4 S Direct
Common Stock Disposition 2025-02-18 80 $259.10 11,989 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 431 Indirect by Managed Account
Common Stock 250 Indirect by Trust
Footnotes
  1. On February 24, 2021, the reporting person was granted a performance-based stock unit (PSU) under the 2018 Stock Incentive Plan. The shares subject to the PSU vest based on the achievement of four specified performance measures. The shares reported were issued to the reporting person upon vesting of one-quarter of the shares subject to the PSU based on the issuer publicly reporting achievement, on or before December 31, 2025, of non-GAAP operating income profitability for a 12-month calendar year, as determined by The People, Culture and Compensation Committee of the Issuer Board of Directors on February 13, 2025.
  2. Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form.
  3. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $251.89 to $252.89. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  4. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $252.90 to $253.89. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  5. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $253.96 to $254.93. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  6. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $254.99 to $255.97. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  7. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $256.01 to $256.84. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  8. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $257.05 to $257.78. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  9. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $257.86 to $258.44. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  10. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $259.21 to $260.14. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  11. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $260.31 to $260.96. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  12. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $261.42 to $261.47. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  13. This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 11, 2024.
  14. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $249.56 to $250.52. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  15. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $250.57 to $251.25. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  16. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $256.00 to $256.95. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  17. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $257.79 to $258.05. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  18. Reflects shares of ALNY common stock acquired by the Reporting Person under the issuer 401(k) plan as a result of the issuer 401(k) matching contribution program.
  19. Represents shares held in trust, of which the Reporting Persons spouse is co-trustee. The Reporting Person disclaims beneficial ownership of these shares, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.